Evaluating the Effectiveness of Imagery Focussed Therapy
1 other identifier
interventional
62
1 country
1
Brief Summary
This study explores the effectiveness of a brief Imagery-focussed Cognitive Therapy (imCT) compared to psychoeducation, regarded as treatment as usual for this patient population, in patients suffering from BD receiving mood stabilising medication. ImCT was successfully tested in a pilot study using a case series design. The investigators now elaborate on this study comparing effectiveness of the intervention to psychoeducation/TAU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2018
CompletedStudy Start
First participant enrolled
October 1, 2018
CompletedFirst Posted
Study publicly available on registry
November 23, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedAugust 31, 2021
August 1, 2021
2.2 years
February 27, 2018
August 30, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline Mood variability to follow up at 16 weeks after end of intervention
Mood variability is measured using the Affect Lability Score Short Version (ALS-18; Oliver \& Simons, 2004). The ALS-18 is a self-report scale measuring lability in affect and consists of 18 items. Ratings are made on a 4-point scale with a maximum score of 72. Scores range from A= very characteristic of me (4 points), to D= very uncharacteristic of me (1 point).
The ALS-18 is administered at T0, after 4 weeks baseline at T1, after the end of intervention (12 weeks in the ImCT condition, and 6 weeks in the psychoeducation condition) T2, 8 weeks after the end of intervention T3, and after 16 weeks follow up -T4.
Secondary Outcomes (7)
Change from baseline Level of depression to follow up at to follow up at 16 weeks
measured weekly throughout the duration of the study in both groups (32 weeks imCT and 26 weeks psychoeducation/TAU).
Change from baseline level of mania to follow up at 16 weeks
measured weekly throughout the duration of the study in both groups ( 32 weeks imCT and 26 weekspsychoeducation/TAU).
Change from baseline level of anxiety to follow up at 16 weeks
measured both daily and weekly throughout the duration of the study in both groups (32 weeks imCT and 26 weeks psychoeducation/TAU)
Change from baseline level of hopelessness to follow up at 16 weeks follow up
measured at baseline (T0), after 4 weeks pre-intervention (T1), post-intervention after 6 weeks in the psychoeduc condition and 12 weeks in the ImCT condition (T2) and at follow up at 8 weeks (T3) and at 16 weeks (T4).
Change from baseline level of general functioning and coping to follow up at 16 weeks
Participants rate their level of functioning at baseline (T0), after 4 weeks pre-intervention (T1), post-intervention12 weeks in the ImCT condition and 6 weeks in the psychoeducation condition (T2) and at follow up at 8 weeks (T3) and at 16 weeks (T4).
- +2 more secondary outcomes
Other Outcomes (3)
General Imagery (frequency of imagery, quality of imagery and appraisals of imagery):
administered at T0, after 4 weeks baseline at T1, after the end of intervention (12 weeks in the ImCT condition, and 6 weeks in the psychoeducation condition) T2, 8 weeks after the end of intervention T3, and after 16 weeks follow up -T4.
Ratings of target imagery (moderator)
Measured weekly throughout the study for 32 weeks in the ImCT condition and 26 weeks in the psychoeducation condition
General Imagery
administered at T0, after 4 weeks baseline at T1, after the end of intervention (12 weeks in the ImCT condition, and 6 weeks in the psychoeducation condition) T2, 8 weeks after the end of intervention T3, and after 16 weeks follow up -T4.
Study Arms (2)
psychoeducation/TAU
ACTIVE COMPARATORTAU consists of psycho-education for a period of 12 weeks, consisting of 6 2-hour sessions. Psycho-education is offered in groups,
imCT intervention
EXPERIMENTALFor a period of 12 weeks, 12 1-hour sessions of imagery-focused Cognitive Therapy delivered weekly by a trained therapists, divided in an in depth identification (4 sessions) of images followed by imagery interventions, (6 sessions) and a consolidation phase (2 sessions).
Interventions
In depth identification phase: Therapists and patient collaboratively map out difficulties and pinpoint a treatment focus. Imagery interventions: The imagery intervention consists of metacognitive imagery rescripting or promoting positive imagery or competing tasks (or a combination of these). Consolidation: Consist of fine tuning the strategies, relapse prevention using a video diary.
Psycho-education is offered in groups, using the format described by Honig (Postma, Honig, \& van Gent, 2008).
Eligibility Criteria
You may qualify if:
- Aged 18-68
- Sufficient Dutch language ability to permit the assessment to be completed.
- Diagnosis of DB (I or II or NOS) according to DSM-5 (clinicians assessment).
- Willing to complete daily and weekly monitoring throughout the duration of the study.
- Successful completion of the daily monitoring in the 4 weeks active run-in phase.
- Willing to be randomised to either imCT or psychoeducation/TAU condition
- Can commit to attending 12 consecutive weekly sessions imCT or psychoeducation/TAU.
You may not qualify if:
- Learning difficulties, organic brain disease or severe neurological impairment.
- Current severe substance or alcohol misuse (clinicians assessment).
- Current manic episode as diagnosed by DSM-5
- Current active psychotic symptoms
- Presence of active suicidal risk as indicated by a score of 2 or more on item 12 (i.e. frequent thought and/or plans to end their life) of the QIDS (Rush et al., 2003) confirmed by convergent clinical opinion.
- Taking part in concurrent treatment studies investigating pharmacological or psychological treatment for BD.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centrum Bipolair, GGzE
Eindhoven, Netherlands
Related Publications (1)
van den Berg KC, Hendrickson AT, Hales SA, Voncken M, Keijsers GPJ. Comparing the effectiveness of imagery focussed cognitive therapy to group psychoeducation for patients with bipolar disorder: A randomised trial. J Affect Disord. 2023 Jan 1;320:691-700. doi: 10.1016/j.jad.2022.09.160. Epub 2022 Oct 5.
PMID: 36206888DERIVED
Related Links
- Applications of time-series analysis to mood fluctuations in bipolar disorder to promote treatment innovation: a case series
- An investigation of mental imagery in bipolar disorder: Exploring "the mind's eye".
- Evidence-based guidelines for treating bipolar disorder Revised third edition recommendations from the British.
- Mental imagery as an emotional amplifier: application to bipolar disorder
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
karin van den Berg
Maastricht University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Psychologist, PhD student Maastricht University
Study Record Dates
First Submitted
February 27, 2018
First Posted
November 23, 2018
Study Start
October 1, 2018
Primary Completion
December 30, 2020
Study Completion
December 30, 2020
Last Updated
August 31, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share